Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

139 public trials 43 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

Phase IIa Study for IPG11406 in Patients With Lupus Nephritis

NCT06717815

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • The First Affiliated Hospital Of Anhui Medical University Hefei, Anhui, China
  • Fujian Medical University Union Hospital Fuzhou, Fujian, China
  • Fujian Provincial Hospital Fuzhou, Fujian, China
  • Sun Yai-sen Memorial Hospital, Sun Yai-sen University Guangzhou, Guandong, China
View all 17 locations
View Trial Details
Completed

A Study to Assess Effectiveness and Safety of Efgartigimod in Chinese Patients With Lupus Nephritis (ZL-1103-013)

NCT05810948

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Peking University Third Hospital Beijing, China
  • Peking University People's Hospital Beijing, China
  • Hunan Provincial People's Hospital Changsha, China
  • The Second Affiliated Hospital of Chongqing Medical University Chongqing, China
View all 31 locations
View Trial Details
Completed

Dose Finding, Efficacy and Safety of BI 655064 in Patients With Active Lupus Nephritis

NCT02770170

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Female Urogenital Diseases, +11 more
Locations
  • Academic Medical Research Institute Los Angeles, California, United States
  • Integrity Clinical Research, LLC Doral, Florida, United States
  • Hope Clinical Research Kissimmee, Florida, United States
  • Integral Rheumatology and Immunology Specialist Plantation, Florida, United States
View all 74 locations
View Trial Details
Completed

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619

Conditions
Autoimmune Diseases, C3 Glomerulonephritis, Connective Tissue Diseases, +18 more
Locations
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • HealthONE Physician Care, Rocky Mountain Hospital for Children Denver, Colorado, United States
  • Washington Nephrology Associates Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details

Related conditions